Continuous glucose monitoring indicates sex is safe for type 1 diabetes patients

New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, from September 28 to October 2, indicates that sexual intercourse is safe for individuals living with type 1 diabetes when continuous glucose monitoring (CGM) devices are used. The findings were unveiled by Dr. Dominica Orłowska of the Medical University of Warsaw and her research team, who analyzed real‑time glucose data collected during intimate activity.

The study employed CGM technology to track blood‑glucose fluctuations in a cohort of adults with type 1 diabetes throughout episodes of sexual activity, comparing the results with baseline glucose patterns. Data showed no significant incidence of hypoglycemia or hyperglycemia attributable to intercourse, and participants reported stable glucose levels within target ranges. These results suggest that, with appropriate CGM use, people with type 1 diabetes can engage in sexual activity without heightened metabolic risk, offering clinicians evidence to support more confident counseling on sexual health for this population.